Steven Roberts, DO
Family Medicine · Bozeman, MTNPI 1699797480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 44.6% of the total. Reporting peaked in 2024 at $522 and has fallen 52.9% since, to $246 in 2025. Among family medicine clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$595
- Pfizer$114
- E.r. Squibb & Sons, L.L.C.$91
- GSK$72
- Novo Nordisk$70
- Sanofi Pasteur Inc.$61
- plus $331 from 11 others
What the payments were for
- Food & beverage$1,334100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $595 |
| Pfizer | 8 | $114 |
| E.r. Squibb & Sons, L.L.C. | 4 | $91 |
| GSK | 4 | $72 |
| Novo Nordisk | 4 | $70 |
| Sanofi Pasteur Inc. | 3 | $61 |
| Boehringer Ingelheim | 2 | $50 |
| Inspire Medical Systems, Inc. | 1 | $46 |
| Exact Sciences | 3 | $46 |
| Lilly USA, LLC | 3 | $43 |
| Astellas Pharma US Inc | 1 | $30 |
| Merck | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
| AstraZeneca | 1 | $13 |
| Nevro Corp. | 1 | $12 |
How this compares
$1,334 in reported general payments places this provider in the 90th percentile of 426 family medicine providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 34 | $33,866 |
| MounjaroTirzepatide | 29 | $30,005 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $25,219 |
| EliquisApixaban | 37 | $25,126 |
| JardianceEmpagliflozin | 26 | $21,913 |
| FarxigaDapagliflozin Propanediol | 15 | $18,448 |
| Fentanyl | 12 | $6,477 |
| Repatha SyringeEvolocumab | 11 | $5,753 |
| Atorvastatin Calcium | 436 | $4,331 |
| Candesartan Cilexetil | 17 | $2,401 |
| Losartan Potassium | 264 | $2,361 |
| Levothyroxine Sodium | 172 | $1,967 |
| Tamsulosin Hcl | 119 | $1,920 |
| Rosuvastatin Calcium | 189 | $1,773 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $1,484 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $16 | $33,86634 claims |
| Lilly USA, LLCMounjaro | $43 | $30,00529 claims |
| GSKTrelegy Ellipta | $72 | $25,21930 claims |
| PfizerEliquis | $114 | $25,12637 claims |
| Boehringer IngelheimJardiance | $50 | $21,91326 claims |
| AstraZenecaFarxiga | $13 | $18,44815 claims |
| AbbVieSynthroid | $595 | $63814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 426 family medicine providers in Montana.
Other family medicine in Bozeman
- Terry EdwardsBozeman$2K
- Logen NunbergBozeman$2K
- Gabor BendaBozeman$2K
- Heather WheelerBozeman$1K
- Christine MitchellBozeman$1K
- Connie HahnBozeman$908
- Thomas HildnerBozeman$748
- Tracy FairbanksBozeman$739
- Kimberly BlakesleeMissoula$186K
- Kathleen Harder-BrouwerHamilton$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.